2024 ICD-10-CM Diagnosis Code C12

by

Malignant neoplasm of pyriform sinus

  • C12 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM C12 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C12 – other international versions of ICD-10 C12 may differ.

Applicable To

  • Malignant neoplasm of pyriform fossa

Use Additional

  • code to identify:
  • exposure to environmental tobacco smoke (Z77.22)
  • exposure to tobacco smoke in the perinatal period (P96.81)
  • history of tobacco dependence (Z87.891)
  • occupational exposure to environmental tobacco smoke (Z57.31)
  • tobacco dependence (F17.-)
  • tobacco use (Z72.0)

The following code(s) above C12 contain annotation back-references

 that may be applicable to C12:

Approximate Synonyms

  • Cancer of the pyriform sinus
  • Primary malignant neoplasm of pyriform sinus

ICD-10-CM C12 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
  • 012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
  • 013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
  • 146 Ear, nose, mouth and throat malignancy with mcc
  • 147 Ear, nose, mouth and throat malignancy with cc
  • 148 Ear, nose, mouth and throat malignancy without cc/mcc

Convert C12 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Code annotations containing back-references to C12:

  • Type 2 Excludes: C13